NeoVisc® is a 1.0% solution of a highly purified, linear high molecular weight sodium hyaluronate which is derived entirely from non-animal sources and used to improve joint mobility and reduce joint pain.
Patients with Osteoarthritis typically experience pain and loss of mobility because of changes to the internal environment of the affected joint. NeoVisc® works as a viscosupplement by improving the natural viscosity and elasticity of synovial fluid, thereby increasing lubrication, improved joint mobility, and a reduction in pain.
NeoVisc® is administered by a physician through a series of intra-articular injections (injections into the synovial space of the joint). Onset of symptomatic relief varies from patient to patient depending on the severity of the patients' osteoarthritis.